More FDA Transparency May Confuse Consumers, Stifle Competition - Industry
This article was originally published in The Tan Sheet
Executive Summary
Some FDA proposals to increase transparency could threaten fair competition, innovation and firms' reputations unless the agency provides disclaimers and cautions consumers about drawing conclusions from the information